Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Injectable Formulations
Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report 2026
An investigational new drug contract development and manufacturing organization (CDMO) is a contract development and manufacturing entity that supports the development and production of pharmaceutical compounds intended for use in clinical trials under an Investigational New Drug application. These organizations operate within the required regulatory frameworks for early-stage drug development, ensuring adherence to guidelines necessary for advancing experimental therapies toward market approval.
Integrase Inhibitors Global Market Report 2026
Integrase inhibitors are a class of antiretroviral drugs that block the action of the HIV enzyme integrase, preventing the integration of viral DNA into the host cell's genome. This inhibition stops the replication of the virus and slows the progression of HIV infection. These inhibitors are primarily used in the treatment of HIV, typically as part of combination therapy to lower viral load and enhance immune function.
Sodium Hyaluronate Crosspolymer Market is Expected to Reach a Valuation of USD 2,000 Million by 2035, Growing at a CAGR of 7.8%
The Sodium Hyaluronate Crosspolymer Market is witnessing remarkable growth, driven primarily by the increasing demand for advanced skincare products and medical formulations. Sodium Hyaluronate Crosspolymer (SHC) is an enhanced form of sodium hyaluronate, known for its superior moisture-retaining and skin-rejuvenating properties. Its unique crosslinked structure allows for prolonged hydration, making it a preferred ingredient in cosmetics, dermatology, and pharmaceutical applications.
Penicillin Drug Market Growth in Future Scope 2025-2032 |Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Amgen Inc
BURLINGAME, CA, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- The qualitative latest Research report (2025-2032) on the Penicillin Drug Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision.
Penicillin Drug Market Growth in Future Scope 2025-2032 |Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Amgen Inc
Penicillin Drug Market Growth in Future Scope 2025-2032 |Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Amgen Inc Penicillin Drug Market Growth 2025-2032 BURLINGAME, CA, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- The qualitative latest Research report (2025-2032) on the Penicillin Drug Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape.
Aminoglycosides Market To Expand At A CAGR Of 6.3% Reaching $2.46 Billion By 2029
2025 Market Reports Update: Forecasts Through 2034, Emerging Trends, Key Players, and Leading Regions – Stay Ahead of the Competition Today! The aminoglycosides by The Business Research Company provides a comprehensive analysis of the industry, covering market size forecasts from 2025 to 2034. The report explores key trends shaping the market, major growth drivers, and detailed segmentation based on [key segment categories].
Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth: Key Roxadustat Market Trend 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Current Market Size And Predicted CAGR For The Roxadustat Market? The Roxadustat market has experienced strong growth in recent years. It will grow from $6.44 billion in 2024 to $6.92 billion in 2025, reflecting a CAGR of 7.5%.
Antispasmodics Drugs Global Market Report 2025
Antispasmodic drugs are medications designed to treat, prevent, or decrease the frequency of muscular spasms, especially those involving smooth muscle, such as those occurring in the walls of the gastrointestinal tract. These drugs function by slowing down the normal movements of the gut and inducing relaxation in the muscles of the stomach and intestines. Key drugs in the category of antispasmodics include dicyclomine hydrochloride, loperamide hydrochloride, and others.
Gastric Cancer Drugs Market Forecast 2025-2034: Comprehensive Insights on Market Size, Growth Factors, Trends, and Competitive Landscape
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Current Market Size And Predicted CAGR For The Gastric Cancer Drugs Market? The gastric cancer drugs market has experienced rapid growth in recent years. It will grow from $4.43 billion in 2024 to $5.01 billion in 2025 at a CAGR of 12.9%.
Prochlorperazine Maleate Market Size, Share Growth Status, Emerging Technology, Challenges, and Forecast till 2031
The Global Prochlorperazine Maleate Market size estimated to be valued at US$ 1.46 billion in 2023 and is expected to reach US$ 1.85 billion by 2030, grow at a compound annual growth rate (CAGR) of 3.4% from 2023 to 2030. The latest market intelligence report published by CMI with the title "Global Prochlorperazine Maleate Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Pharmaceutical industry.
In-Depth Analysis and Future Growth Outlook of the Prochlorperazine Maleate Market Advancements Highlighted by Key Trends, Market Drivers, and Growth Forecast 2024-2031
The Global Prochlorperazine Maleate Market size estimated to be valued at US$ 1.46 billion in 2023 and is expected to reach US$ 1.85 billion by 2030, grow at a compound annual growth rate (CAGR) of 3.4% from 2023 to 2030. Market Overview: Prochlorperazine maleate is an antiemetic and antipsychotic phenothiazine derivative used for the treatment of nausea, vomiting, migraines and psychotic disorders. It works by blocking dopamine receptors in the brain.
Prochlorperazine Maleate Market 2023 | Industry Structure And Landscape Development 2030 | GlaxoSmithKline plc, Pfizer Inc., Novartis AG, AstraZeneca plc, Teva Pharmaceutical Industries Ltd.
Coherent Market Insights recently published a premium market research endeavor titled “Prochlorperazine Maleate Market: Size, Emerging Trends, Share, Remarkable Growth, Segmentation, Analysis, and Projection, 2030.” This report performs a comprehensive analysis of the Prochlorperazine Maleate Market and explores the factors driving its growth and creating opportunities.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Injectable
Contact Injectable, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack